# clm_EE8DEE22E155

subject: Novartis (/record/novartis.md)  
predicate: operating_income  
value: 8,268,000,000 United States dollar  
valid_from: 2016-12-31  
valid_to: 2017-12-31  
published: 2019-01-30  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_0526738C57FA  
last_updated: 2026-11-08  
cite: AsOf. "Novartis operating income: 8,268,000,000 United States dollar", as of 2016-12-31 (until 2017-12-31). Claim clm_EE8DEE22E155, https://asof.is/claim/clm_EE8DEE22E155, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1114448/000137036819000002/0001370368-19-000002-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: ifrs-full:ProfitLossFromOperatingActivities in 20-F FY2018, filed 2019-01-30  

## Sources

- https://www.sec.gov/Archives/edgar/data/1114448/000137036819000002/0001370368-19-000002-index.htm (primary, SEC EDGAR 20-F FY2018, published 2019-01-30)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.